C-reactive protein and dialysis access

Slides:

Advertisements

Similar presentations

Kamyar Kalantar-Zadeh Kidney International

Advertisements

Volume 65, Issue 6, Pages (June 2004)

E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P

Beta blockers in the management of chronic kidney disease

Use of hemodialysis and hemoperfusion in poisoned patients

Anemia management in chronic kidney disease

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

C-reactive protein and dialysis access

Volume 55, Issue 2, Pages (February 1999)

Fibrin plug Kidney International Volume 78, Issue 9, (November 2010)

Volume 80, Issue 10, Pages (November 2011)

Volume 75, Issue 11, Pages (June 2009)

Volume 54, Issue 2, Pages (August 1998)

Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Sanjeev Kumar, Stanley L.-S. Fan, Martin.

Kamyar Kalantar-Zadeh Kidney International

Malnutrition and inflammation in peritoneal dialysis patients

Volume 80, Issue 9, Pages (November 2011)

Volume 73, Issue 5, Pages (March 2008)

Comorbidity and confounding in end-stage renal disease

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

Volume 86, Issue 1, Pages (July 2014)

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 74, Issue 3, Pages (August 2008)

Volume 77, Issue 2, Pages (January 2010)

Volume 65, Issue 2, Pages (February 2004)

Nephrology Crosswords: Hemodialysis

Volume 87, Issue 2, Pages (February 2015)

The calcium–phosphorus in guidelines for CKD-MBD

Prescribing and monitoring hemodialysis dose

Blood pressure targets in hemodialysis patients

Volume 65, Issue 6, Pages (June 2004)

The dynamics of prognostic indicators: toward earlier identification of dialysis patients with a high risk of dying Charles Chazot, Guillaume Jean Kidney.

Volume 76, Issue 6, Pages (September 2009)

Yijian Huang, Rebecca Zhang, Steven D. Culler, Nancy G. Kutner

Effects of hemodialysis on cardiac function

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Volume 71, Issue 6, Pages (March 2007)

Hepatitis C treatment in patients with kidney disease

Volume 85, Issue 1, Pages 3-4 (January 2014)

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

Volume 62, Issue 4, Pages (October 2002)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Volume 82, Issue 9, Pages (November 2012)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Daily nocturnal home hemodialysis

Volume 74, Issue 9, Pages (November 2008)

Peter G. Blake, Arsh K. Jain, Sechelle Yohanna Kidney International

Organ transplantation goes to the movies

Volume 80, Issue 10, Pages (November 2011)

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

Volume 80, Issue 10, Pages (November 2011)

Collapsing glomerulopathy: beyond serendipity in mouse genetics

Volume 70, Issue 7, Pages (October 2006)

Charles A. Herzog Kidney International

Victoria R. Briggs, Badri M. Shrestha, Martin E. Wilkie

Volume 64, Issue 3, Pages (September 2003)

Volume 82, Issue 9, Pages (November 2012)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 76, Issue 5, Pages (September 2009)

Increased fetuin-A levels following treatment with a vitamin D analog

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Volume 74, Issue 10, Pages (November 2008)

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Victoria A. Kumar, Margo A. Sidell,

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

C-reactive protein and dialysis access Eric P. Cohen, Jean-Marie Krzesinski Kidney International Volume 76, Issue 10, Pages 1025-1026 (November 2009) DOI: 10.1038/ki.2009.301 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan–Meier estimate of survival in hemodialysis patients with serum C-reactive protein (CRP) levels in the highest quartile, middle two quartiles, and lowest quartile. *P=0.0015 vs CRP <2.6μg/ml; **P=0.0090 vs CRP <2.6μg/ml; †P=0.0028 vs CRP2.6–5.2μg/ml; ‡P=0.0012 vs CRP <5.3–11.5μg/ml; §P=0.0001 vs CRP <2.6μg/ml. (Adapted with permission from ref. 15.) Kidney International 2009 76, 1025-1026DOI: (10.1038/ki.2009.301) Copyright © 2009 International Society of Nephrology Terms and Conditions